Literature DB >> 4393214

The effect of "selective" beta-adrenoceptor blocking drugs on the myocardial circulation.

J R Parratt, R M Wadsworth.   

Abstract

1. A comparison has been made of the effects of a relatively specific beta(1)-adrenoceptor blocking drug (practolol) and a relatively specific beta(2)-adrenoceptor blocking drug (butoxamine) on myocardial and general haemodynamics in anaesthetized cats.2. Practolol, in a dose (10 mg/kg, intravenously) which had little effect on arterial pressure, heart rate, myocardial blood flow or myocardial vascular resistance, markedly reduced the effects of isoprenaline infusions on heart rate, aortic dp/dt, myocardial blood flow, vascular resistance and metabolic heat production, and the cardiac effort index. Isoprenaline induced vasodepression was unaffected.3. Butoxamine (5 mg/kg, intravenously) decreased heart rate, aortic dp/dt, the cardiac effort index and myocardial blood flow and increased myocardial vascular resistance. This is taken as further evidence for the existence of beta(2)-adrenoceptors in the myocardial microcirculation.4. After butoxamine, the effects of isoprenaline on myocardial blood flow, myocardial vascular resistance and heart rate were unaffected but the peripheral vasodilator effect was abolished. The effects on aortic dp/dt and the cardiac effort index were potentiated.5. It is concluded that the effect of isoprenaline in increasing myocardial blood flow is due predominantly to increased cardiac work and oxygen consumption and that practolol, since it has little direct effect on myocardial blood flow yet abolishes the cardiac stimulant and oxygen wasting effects of released catecholamines, has properties which indicate that it should be an effective and safe anti-anginal drug.

Entities:  

Mesh:

Substances:

Year:  1970        PMID: 4393214      PMCID: PMC1702852          DOI: 10.1111/j.1476-5381.1970.tb12893.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  23 in total

1.  Effects of adrenaline and noradrenaline on coronary blood flow before and after beta-adrenergic blockade.

Authors:  P G Gaal; A A Kattus; A Kolin; G Ross
Journal:  Br J Pharmacol Chemother       Date:  1966-03

Review 2.  The development of beta adrenergic blocking drugs: a retrospective and prospective evaluation.

Authors:  N C Moran
Journal:  Ann N Y Acad Sci       Date:  1967-02-10       Impact factor: 5.691

3.  The pharmacological differentiation of adrenergic receptors.

Authors:  R F Furchgott
Journal:  Ann N Y Acad Sci       Date:  1967-02-10       Impact factor: 5.691

4.  Myocardial vascular reactivity after beta-adrenergic blockade.

Authors:  J R Parratt; J Grayson
Journal:  Lancet       Date:  1966-02-12       Impact factor: 79.321

5.  Relation of heart rate and systolic blood pressure to the onset of pain in angina pectoris.

Authors:  B F Robinson
Journal:  Circulation       Date:  1967-06       Impact factor: 29.690

6.  The effect of butoxamine on catecholamine-induced metabolic changes in humans.

Authors:  D B Hunninghake; D L Azarnoff; D Waxman
Journal:  Clin Pharmacol Ther       Date:  1966 Jul-Aug       Impact factor: 6.875

7.  Pharmacological characterization of adrenergic receptors.

Authors:  N C Moran
Journal:  Pharmacol Rev       Date:  1966-03       Impact factor: 25.468

8.  Differentiation of receptor systems activated by sympathomimetic amines.

Authors:  A M Lands; A Arnold; J P McAuliff; F P Luduena; T G Brown
Journal:  Nature       Date:  1967-05-06       Impact factor: 49.962

9.  Dimethyl isopropylmethoxamine: a selective beta-receptor blocking agent.

Authors:  B Levy
Journal:  Br J Pharmacol Chemother       Date:  1966-08

10.  The adrenergic blocking activity of N-tert.-butylmethoxamine (butoxamine).

Authors:  B Levy
Journal:  J Pharmacol Exp Ther       Date:  1966-03       Impact factor: 4.030

View more
  19 in total

1.  Effects of atenolol on regional myocardial blood flow and ST segment elevation in the canine myocardium.

Authors:  A Berdaux; J R Bossier; J F Giudicelli
Journal:  Br J Pharmacol       Date:  1977-07       Impact factor: 8.739

2.  Comparative effects of propranolol and practolol in the early stages of experimental canine myocardial infarction.

Authors:  R J Marshall; J R Parratt
Journal:  Br J Pharmacol       Date:  1976-06       Impact factor: 8.739

3.  Lack of an effect of soman on norepinephrine-induced relaxations of porcine coronary arteries.

Authors:  C Y Hu; C P Robinson
Journal:  Bull Environ Contam Toxicol       Date:  1990-04       Impact factor: 2.151

4.  Cardio-selective beta-adrenoceptor blockade and the coronary circulation.

Authors:  K R Adam; S Boyles; P C Scholfield
Journal:  Br J Pharmacol       Date:  1970-11       Impact factor: 8.739

5.  Cardioselective beta-adrenergic blockade.

Authors:  J D Fitzgerald
Journal:  Proc R Soc Med       Date:  1972-09

6.  The effects of dipyridamole on the myocardial vasodilator actions of noradrenaline, isoprenaline and adenosine.

Authors:  J R Parratt; R M Wadsworth
Journal:  Br J Pharmacol       Date:  1972-12       Impact factor: 8.739

7.  Effect of beta-adrenoceptor blocking compounds (propranolol, practolol and LB 46) on isoprenaline induced changes in regional blood flow in the rat.

Authors:  L Debreczeni; T Fenyvesi
Journal:  Br J Pharmacol       Date:  1971-02       Impact factor: 8.739

8.  The release of a coronary vasodilator metabolite from the guinea-pig isolated perfused heart stimulated by catecholamines, histamine and electrical pacing and by exposure to anoxia.

Authors:  K J Broadley
Journal:  Br J Pharmacol       Date:  1976-09       Impact factor: 8.739

9.  Characterization of the coronary vascular -adrenoceptor in the pig.

Authors:  G M Drew; G P Levy
Journal:  Br J Pharmacol       Date:  1972-10       Impact factor: 8.739

10.  Determination of infundibular innervation and amine receptor content in cyanotic and acyanotic myocardium: relation to clinical events in tetralogy of Fallot.

Authors:  L B McGrath; C Chen; J Gu; J Bianchi; J M Levett
Journal:  Pediatr Cardiol       Date:  1991-07       Impact factor: 1.655

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.